RTA Laboratuvarları Biyoloji Anonim Şirketi (RTALB.IS) at a glance
RTA Laboratuvarları Biyoloji Anonim Şirketi (RTALB.IS) is a small-cap Healthcare company. It trades at $2.9, with a P/E of 5.1, a 118.8% profit margin and revenue growth of 20.8%. It does not pay a dividend. Vestovix scores it 75/100 overall. Its strongest dimension is Value (99/100) and its weakest is Momentum (16/100). It is a relatively defensive holding with below-market volatility.
- Price
- TRY 2.90
- Market cap
- $1.52B
- P/E ratio
- 5.1
- Dividend yield
- None
- Beta
- 0.40
- 52-week range
- TRY 2.78 to TRY 5.08
Value
99
Growth
87
Income
40
Safety
94
Momentum
16
Other Healthcare stocks
See allSELEC.IS--
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
TRY 324.00+8.00%
0.15% yield
MPARK.IS--
MLP Saglik Hizmetleri A.S.
TRY 434.00-0.74%
ECILC.IS--
Eis Eczacıbaşı İlaç ve Sanayi A.Ş.
TRY 76.50-1.61%
2.21% yield
GENIL.IS--
Gen Ilac ve Saglik Urunleri A.S.
TRY 12.04-1.23%
0.19% yield
DEVA.IS--
Deva Holding A.S.
TRY 90.50-0.88%
TNZTP.IS--
Tapdi Oksijen Özel Sağlik Hizmetleri A.Ş.
TRY 30.28+1.34%
EGEPO.IS--
Nasmed Ozel Saglik Hizmetler A.S.
TRY 16.27-2.81%
ONCSM.IS--
Oncosem Onkolojik Sistemler A.Ş.
TRY 255.25-3.04%
0.33% yield